freamine iii- isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine, alanine, arginine, histidin
b. braun medical inc. - isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), alanine (unii: of5 - isoleucine 0.69 g in 100 ml - parenteral nutrition with 10% freamine® iii (amino acid injection) is indicated to prevent nitrogen loss or treat negative nitrogen balance in adults and pediatric patients where (1) the alimentary tract, by the oral, gastrostomy, or jejunostomy route, cannot or should not be used, or adequate protein intake is not feasible by these routes; (2) gastrointestinal absorption of protein is impaired; or (3) protein requirements are substantially increased as with extensive burns. dosage, route of administration, and concomitant infusion of nonprotein calories are dependent on various factors, such as nutritional and metabolic status of the patient, anticipated duration of parenteral nutritional support, and vein tolerance. see warnings, precautions, pediatric use , and dosage and administration. central venous infusion should be considered when amino acid solutions are to be admixed with hypertonic dextrose to promote protein synthesis in hypercatabolic or severely depleted patients, or those requiring long-term
freamine hbc- isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine, alanine, arginine, histidin
b. braun medical inc. - isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), alanine (unii: of5 - isoleucine 0.76 g in 100 ml - parenteral nutrition with 6.9% freamine hbc® (amino acid injection) is indicated to prevent nitrogen loss or treat negative nitrogen balance in adults where (1) the alimentary tract, by the oral, gastrostomy, or jejunostomy route, cannot or should not be used, or adequate protein intake is not feasible by these routes; (2) gastrointestinal absorption of protein is impaired; or (3) nitrogen homeostasis is substantially impaired as with severe trauma or sepsis. dosage, route of administration, and concomitant infusion of non-protein calories are dependent on various factors, such as nutritional and metabolic status of the patient, anticipated duration of parenteral nutritional support, and vein tolerance. see dosage and administration . central venous infusion should be considered when amino acid solutions are to be admixed with hypertonic dextrose to promote protein synthesis in hypercatabolic or severely depleted patients, or those requiring long-term parenteral nutrition. for moderately catabolic or deplet
hepatamine- isoleucine, leucine, lysine acetate, methionine, phenylalanine, threonine, tryptophan, valine, alani injection, solu
b. braun medical inc. - isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), alanine (unii: of5 - isoleucine 0.9 g in 100 ml - hepatamine® is indicated for the treatment of hepatic encephalopathy in patients with cirrhosis or hepatitis. hepatamine® provides nutritional support for patients with these diseases of the liver who require parenteral nutrition and are intolerant of general purpose amino acid injections, which are contraindicated in patients with hepatic coma. hepatamine® is contraindicated in patients with anuria, inborn errors of amino acid metabolism, especially those involving branched chain amino acid metabolism such as maple syrup urine disease and isovaleric acidemia, or hypersensitivity to one or more amino acids present in the solution.
isoleucine 50mg/5ml oral solution
special order - l-isoleucine - oral solution - 10mg/1ml
l-isoleucine 25 2.5g oral powder sachets
nutricia ltd - l-isoleucine - oral powder - 2.5gram
l-isoleucine
ceva animal health pty ltd - isoleucine - l - unknown - isoleucine - l amino acid-isoleucine-l active 0.0 - active constituent
l-isoleucine high 7412- l-isoleucine high liquid
professional complementary health formulas - l-isoleucine 15x, 20x, 30x, 60x, 200x - for the temporary relief of tiredness, general weakness, muscle fatigue, occasional headache, dizziness, sadness, confusion, or irritability.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.
l-isoleucine 7411- l-isoleucine liquid
professional complementary health formulas - l-isoleucine 4x, 7x, 12x - for the temporary relief of tiredness, general weakness, muscle fatigue, occasional headache, dizziness, sadness, confusion, or irritability.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.
aminosteril ke 10% carbohydrate free solution for infusion
fresenius kabi south africa (pty) limited stand 7 growthpoint park 2 tonetti street halfway - l-isoleucine l-leucine l-lysine l-methionine - solution for infusion - l-isoleucine 4.67g l-leucine 7.06g l-lysine 5.91g - intravenous solutions: solutions for parenteral
precopar infusion
pt sanbe farma jl taman sari no.10 bandung indonesia - l-isoleucine l-leucine l-valine l-arginine - infusion - l-isoleucine : 4.225 g l-leucine : 4.730 g - intravenous solutions: solutions for parenteral